HISTONE DEACETYLASE INHIBITORS FOR CANCER THERAPY

被引：0
|
作者：
Carlo-Stella, C. [1 ,2 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Cristina Gandini Med Oncol, Milan, Italy
[2] Univ Milan, Med Oncol, Milan, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [21] Histone deacetylase inhibitors in programmed cell death and cancer therapy
    Marks, PA
    Jiang, XJ
    CELL CYCLE, 2005, 4 (04) : 549 - 551
  • [22] Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
    Ai, T.
    Cui, H.
    Chen, L.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (04) : 475 - 487
  • [23] Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?
    Johnstone, RW
    Licht, JD
    CANCER CELL, 2003, 4 (01) : 13 - 18
  • [24] Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
    Urbinati, Giorgia
    Marsaud, Veronique
    Plassat, Vincent
    Fattal, Elias
    Lesieur, Sylviane
    Renoir, Jack-Michel
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 397 (1-2) : 184 - 193
  • [25] Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
    Tu, Bin
    Zhang, Meng
    Liu, Tuanbing
    Huang, Yongzhuo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [26] Histone deacetylase inhibitors open new doors in cancer therapy
    McLaughlin, F
    La Thangue, NB
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1139 - 1144
  • [27] The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
    Psilopatis, Iason
    Garmpis, Nikolaos
    Garmpi, Anna
    Vrettou, Kleio
    Sarantis, Panagiotis
    Koustas, Evangelos
    Antoniou, Efstathios A.
    Dimitroulis, Dimitrios
    Kouraklis, Gregory
    Karamouzis, Michail V.
    Marinos, Georgios
    Kontzoglou, Konstantinos
    Nonni, Afroditi
    Nikolettos, Konstantinos
    Fleckenstein, Florian N.
    Zoumpouli, Christina
    Damaskos, Christos
    CANCERS, 2023, 15 (08)
  • [28] Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
    Kraft, Fabian B.
    Hanl, Maria
    Feller, Felix
    Schaeker-Huebner, Linda
    Hansen, Finn K.
    PHARMACEUTICALS, 2023, 16 (03)
  • [29] Histone Deacetylase Inhibitors and Bladder Cancer
    Adam, Rosalyn M.
    JOURNAL OF UROLOGY, 2010, 183 (06): : 2120 - 2121
  • [30] Acetylation and histone deacetylase inhibitors in cancer
    Kortenhorst, Madeleine S. Q.
    Carducci, Michael A.
    Shabbeer, Shabana
    CELLULAR ONCOLOGY, 2006, 28 (5-6) : 191 - 222
12345